Published • loading... • Updated
Abbott Agrees to Pay Over $384M to Settle FCA Allegations Involving Potentially Contaminated Infant Formula - Constantine LLP
Summary by constantinellp.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Abbott Agrees to Pay Over $384M to Settle FCA Allegations Involving Potentially Contaminated Infant Formula - Constantine LLP
By the Constantine LLP Whistleblower Team On September 14, the DOJ announced that Illinois-based healthcare company Abbott Laboratories (Abbott) agreed to pay more than $384 million to resolve allegations that it caused the submission of false claims involving potentially contaminated products to federal and state programs from Jan. 1, 2018 through Dec. 31, 2022. The DOJ... Read Abbott Agrees to Pay Over $384M to Settle FCA Allegations Involving…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
